Atrial natriuretic peptide, ventricular myocyte hypertrophy, and hemodynamic overload
Benvenuti, L.A.; Higuchi, M.L.; Aiello, V.D.
Circulation 96(8): 2733-2734
1997
ISSN/ISBN: 0009-7322 PMID: 9355918 Document Number: 473350
Document emailed within 1 workday
Related Documents
Iso, T.; Arai, M.; Wada, A.; Kogure, K.; Suzuki, T.; Nagai, R. 1997: Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natriuretic peptide expression American Journal of Physiology 273(1 Pt 2): H113-H118Saito, S.; Nishiuchi, T.; Kojima, A. 1987: Atrial natriuretic peptide. Factors regulating release of atrial natriuretic peptide and its metabolism Nihon Rinsho. Japanese Journal of Clinical Medicine 45(11): 2573-2580
Drouin, J.; Lavigne, J.P.; Nemer, M. 1988: Expression of the gene for the atrial natriuretic factor: a marker for ventricular hypertrophy L'Union Medicale du Canada 117(1): 64-67
Thomsen, J.K.; Fogh-Andersen, N.; Jaszczak, P.; Giese, J. 1993: Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation Acta Obstetricia et Gynecologica Scandinavica 72(2): 103-110
Takeda, S.; Tomaru, T.; Inada, Y. 1992: Hemodynamic effects of infusions of alpha-human atrial natriuretic peptide in anesthetized dogs Masui. Japanese Journal of Anesthesiology 41(4): 566-577
Soualmia, H.; Ayadi, I.; Omar, S.; Feki, M.; Drissa, H.; Mebazaa, A.; Kaabachi, N. 2009: Atrial Natriuretic Peptide and Brain Natriuretic Peptide Release in Human Essential Hypertension Clinical Laboratory 55(3-4): 120-127
Wang, T. 1990: Relation of the plasma level of atrial natriuretic peptide and hemodynamic parameters in patients with chronic obstructive pulmonary disease Zhonghua Yi Xue Za Zhi 70(3): 148-150
Indolfi, C.; Piscione, F.; Volpe, M.; Lembo, G.; De Campora, P.; Russolillo, E.; Ambrosini, V.; Condorelli, M.; Chiariello, M. 1991: The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure Cardiologia 36(5): 351-356
Turski, B.K.; Gembicka-Kuzak, D.M.; Debinski, W.B.; Kuzak, W. 1995: Relationship between atrial natriuretic peptide (ANP), renin (PRA), aldosterone (PAC), hemodynamic responses to lower body negative pressure (LBNP) and +Gz tolerance Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 2(1): P37-P38
Liu, Y.; Xiao, Y.; Chen, X.; Zhang, F. 2014: Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis Chinese Medical Journal 127(15): 2824-2828
Fan, D.; Wannenburg, T.; de Tombe, P.P. 1997: Decreased myocyte tension development and calcium responsiveness in rat right ventricular pressure overload Circulation 95(9): 2312-2317
Anversa, P.; Loud, A.V.; Levicky, V.; Guideri, G. 1985: Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy American Journal of Physiology 248(6 Pt 2): H876-H882
Dabrowski, R.ł; Borowiec, A.; Janas, J.; Firek, B.; Kowalik, I.; Smolis-Bak, E.; Luczak, D.; Sosnowski, C.; Kazimierska, B.; Szwed, H. 2010: High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation Kardiologia Polska 68(8): 893-900
Wozakowska-Kapłon, B.; Opolski, G.; Janion, M. 2003: Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation Kardiologia Polska 58(4): 255-263
Majunke, N.; Sandri, M.; Adams, V.; Daehnert, I.; Mangner, N.; Schuler, G.; Moebius-Winkler, S. 2015: Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage with the Watchman Device Journal of Invasive Cardiology 27(10): 448-452
Ionescu, V.; Adamache, A.; Stoiculescu, P. 1970: Disorders of left ventricular repolarization in right ventricular hemodynamic overload Revue Roumaine de Physiologie 7(3): 235-244
Schnee, P.M.; Shah, N.; Bergheim, M.; Poindexter, B.J.; Buja, L.M.; Myers, T.J.; Radovancevic, B.; Frazier, O.H.; Bick, R.J. 2006: Reversal of myocyte hypertrophy by ventricular unloading: cardiac improvement without adrenergic receptor up-regulation and relocalization Medgenmed: Medscape General Medicine 8(2): 45
Yang, X.P.; Samaja, M.; English, E.; Benatti, P.; Tarantola, M.; Cardace, G.; Motterlini, R.; Micheletti, R.; Bianchi, G. 1992: Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy Journal of Cardiovascular Pharmacology 20(1): 88-98
Gunther, S.; Grossman, W. 1979: Determinants of ventricular function in pressure-overload hypertrophy in man Circulation 59(4): 679-688
Olivera, A.; López Novoa, J.M. 1987: Atrial natriuretic peptide Revista Clinica Espanola 181(1): 32-36